Stay updated on ZPL389 Safety and Efficacy in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the ZPL389 Safety and Efficacy in Atopic Dermatitis Clinical Trial page.

Latest updates to the ZPL389 Safety and Efficacy in Atopic Dermatitis Clinical Trial page
- Check2 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedUpgrade to v3.2.0 with a new government-operational status notice; removes v3.1.0 and adds versioned update text and current operating status details.SummaryDifference3%
- Check24 days agoChange DetectedVersion update: add v3.1.0; remove several drug-safety topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) and the prior version marker v3.0.2.SummaryDifference0.3%
- Check38 days agoChange DetectedOnly a version bump from v3.0.1 to v3.0.2 and removal of a Back to Top element were made. No changes to core content, pricing, stock, or time slot availability.SummaryDifference0.2%
- Check45 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content, names, pricing, or availability.SummaryDifference0.2%
- Check52 days agoChange DetectedThe web page has undergone significant updates, including the addition of numerous facility names and locations across various countries, while also removing outdated location terms and formatting inconsistencies.SummaryDifference7%
- Check67 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12, indicating a revision in the content.SummaryDifference0.1%
Stay in the know with updates to ZPL389 Safety and Efficacy in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ZPL389 Safety and Efficacy in Atopic Dermatitis Clinical Trial page.